22nd Century - 14 Year Stock Price History | XXII
Historical daily share price chart and data for 22nd Century since 2011 adjusted for splits and dividends. The latest closing stock price for 22nd Century as of April 17, 2025 is 0.78.
- The all-time high 22nd Century stock closing price was 12555.00 on March 10, 2014.
- The 22nd Century 52-week high stock price is 266.22, which is 34030.8% above the current share price.
- The 22nd Century 52-week low stock price is 0.70, which is 10.3% below the current share price.
- The average 22nd Century stock price for the last 52 weeks is 54.42.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| 22nd Century Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
3.0166 |
5.6000 |
8.1000 |
0.7580 |
0.7750 |
-85.40% |
| 2024 |
71.9242 |
24.3000 |
480.6000 |
4.3700 |
5.3100 |
-78.88% |
| 2023 |
874.7442 |
1844.1700 |
2450.2500 |
24.5295 |
25.1370 |
-98.65% |
| 2022 |
3508.2683 |
6075.0000 |
6075.0000 |
1660.5000 |
1864.0100 |
-70.21% |
| 2021 |
6845.9473 |
4374.0000 |
11380.5000 |
4333.5000 |
6257.2500 |
40.45% |
| 2020 |
1892.7771 |
2308.5000 |
5143.5000 |
1133.6000 |
4455.0000 |
100.00% |
| 2019 |
3897.4725 |
5406.7500 |
5771.2500 |
1670.6300 |
2227.5000 |
-55.82% |
| 2018 |
5284.8470 |
6500.2500 |
8424.0000 |
4090.5000 |
5042.2500 |
-11.07% |
| 2017 |
3616.2259 |
2207.2500 |
6905.2500 |
1701.0000 |
5670.0000 |
156.88% |
| 2016 |
2032.1473 |
2835.0000 |
3118.5000 |
1458.0000 |
2207.2500 |
-22.14% |
| 2015 |
2137.9631 |
3543.7500 |
3543.7500 |
1154.2500 |
2835.0000 |
-15.15% |
| 2014 |
5523.3490 |
4191.7500 |
12555.0000 |
3118.5000 |
3341.2500 |
-22.90% |
| 2013 |
2075.8154 |
1417.5000 |
4333.5000 |
1174.5000 |
4333.5000 |
185.33% |
| 2012 |
1014.6343 |
830.2500 |
2227.5000 |
405.0000 |
1518.7500 |
78.57% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.005B |
$0.032B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
